Clinical Trials for Krystal Biotech

Explore 10 clinical trials worldwide

Showing 1-10 of 10 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Krystal Biotech

Clinical Trials (10)

NCT07016750
A Study Assessing KB803 Compared to Matching Placebo for the Treatment and Prevention of Corneal Abrasions in Dystrophic Epidermolysis Bullosa
PHASE3Recruiting
16 participants
Started: Jun 20, 2025 · Completed: Mar 31, 2026
4 conditions1 sponsor4 locations
NCT06999733
A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis
PHASE1/PHASE2Recruiting
27 participants
Started: May 31, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor6 locations
NCT06724900
A Study Assessing KB304 for the Treatment of Wrinkles in Women
PHASE1/PHASE2Active, not recruiting
19 participants
Started: Nov 20, 2024 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT06563414
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
N/ARecruiting
40 participants
Started: Aug 2, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
PHASE1/PHASE2Recruiting
200 participants
Started: Apr 17, 2024 · Completed: Feb 29, 2028
5 conditions1 sponsor11 locations
NCT06049082
A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
PHASE1Recruiting
15 participants
Started: Feb 15, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT05970497
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
240 participants
Started: Oct 31, 2023 · Completed: Jul 31, 2027
4 conditions1 sponsor15 locations
NCT05504837
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
PHASE1Recruiting
12 participants
Started: Jun 30, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor5 locations
NCT04917887
Long-Term Follow-up Protocol
N/ARecruiting
50 participants
Started: May 25, 2021 · Completed: May 25, 2028
3 conditions1 sponsor3 locations
NCT04540900
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
PHASE1Active, not recruiting
85 participants
Started: Oct 7, 2020 · Completed: May 31, 2029
4 conditions1 sponsor4 locations